share_log

What Does Astrana Health, Inc.'s (NASDAQ:ASTH) Share Price Indicate?

What Does Astrana Health, Inc.'s (NASDAQ:ASTH) Share Price Indicate?

Astrana Health,Inc.(NASDAQ:ASTH)的股票價格表示了什麼?
Simply Wall St ·  07/12 19:35

While Astrana Health, Inc. (NASDAQ:ASTH) might not have the largest market cap around , it led the NASDAQCM gainers with a relatively large price hike in the past couple of weeks. The recent jump in the share price has meant that the company is trading at close to its 52-week high. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine Astrana Health's valuation and outlook in more detail to determine if there's still a bargain opportunity.

雖然 Astrana Health, Inc. (納斯達克:ASTH) 的市值可能不是最大的,但在過去幾週中,它帶領 NASDAQ 漲幅領先者取得了相對較大的漲幅。股價最近的上漲意味着公司交易接近 52 周的高點。因爲許多分析師報道了該股,我們可以預計任何價格變動的公告已經被計入了股價。然而,這支股票仍然以相對便宜的價格交易嗎?讓我們更詳細地研究 Astrana Health 的估值和前景,以確定是否仍有便宜的機會。

What's The Opportunity In Astrana Health?

Astrana Health 的機會是什麼?

Astrana Health is currently expensive based on our price multiple model, where we look at the company's price-to-earnings ratio in comparison to the industry average. In this instance, we've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. We find that Astrana Health's ratio of 35.25x is above its peer average of 24.73x, which suggests the stock is trading at a higher price compared to the Healthcare industry. But, is there another opportunity to buy low in the future? Since Astrana Health's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

基於我們的價格多重模型,Astrana Health 目前價格過高,其中我們查看公司的市盈率與行業平均水平相比較。在這種情況下,我們已經使用市盈率(PE)比率,因爲沒有足夠的信息可靠地預測該股票的現金流。我們發現 Astrana Health 的比率爲 35.25x,高於同業平均水平 24.73x,這表明該股票與醫療保健行業相比交易價格較高。但是,未來是否還有另一個低買的機會呢?由於 Astrana Health 的股價相當不穩定,這可能意味着它未來會下跌(或上升得更高),給我們另一個投資機會。這基於其高貝塔值,它是股票相對於市場的移動程度的很好指標。

What does the future of Astrana Health look like?

Astrana Health 的未來如何?

big
NasdaqCM:ASTH Earnings and Revenue Growth July 12th 2024
NasdaqCM:ASTH 營業收入和增長情況2024年7月12日

Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. With profit expected to grow by 68% over the next couple of years, the future seems bright for Astrana Health. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

未來前景是考慮購買股票時的重要因素,尤其是如果您是尋找投資組合增長的投資者。儘管價值投資者會認爲內在價值相對於價格最重要,但更具說服力的投資論點將是高增長潛力以便宜的價格。隨着預計淨利潤在未來幾年增長 68%,Astrana Health 的未來看起來光明。這意味着該股票的現金流將增加,這應該反映在更高的股票估值中。

What This Means For You

這對您意味着什麼?

Are you a shareholder? It seems like the market has well and truly priced in ASTH's positive outlook, with shares trading above industry price multiples. At this current price, shareholders may be asking a different question – should I sell? If you believe ASTH should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

您是股東嗎?市場似乎已經完全將 ASTH 的積極前景定價,股價高於行業價格倍數。在當前價格,股東可能會問一個不同的問題 - 我應該賣出嗎?如果您認爲 ASTH 應該低於當前價格,則在其價格接近行業市盈率比率時高價出售並再次購買可能會有盈利。但在做出這個決定之前,先看看其基本面是否發生了變化。

Are you a potential investor? If you've been keeping tabs on ASTH for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the positive outlook is encouraging for ASTH, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.

您是否是潛在投資者?如果您一直關注 ASTH,那麼現在可能不是最佳時機購買該股票。價格已超過同業水平,這意味着不太可能有更多的錯價收益。然而,積極的前景鼓舞人心,這意味着有必要深入研究其他因素,以便在下次價格下跌時利用機會。

In light of this, if you'd like to do more analysis on the company, it's vital to be informed of the risks involved. For example, we've discovered 1 warning sign that you should run your eye over to get a better picture of Astrana Health.

因此,如果您想更多地分析該公司,了解有關涉及風險的信息至關重要。例如,我們已經發現了 1 個警告信號,您應該仔細研究,以獲得 Astrana Health 更準確的圖片。

If you are no longer interested in Astrana Health, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您對 Astrana Health 不再感興趣,您可以使用我們的免費平台查看我們的超過 50 支具有高增長潛力的股票列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?關注內容?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對本文有反饋? 對內容感到擔憂? 請直接與我們聯繫。 或者,發送電子郵件至editorial-team@simplywallst.com。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論